» Articles » PMID: 29540671

Phosphorylation-dependent Stabilization of MZF1 Upregulates N-cadherin Expression During Protein Kinase CK2-mediated Epithelial-mesenchymal Transition

Overview
Journal Oncogenesis
Date 2018 Mar 16
PMID 29540671
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Epithelial-mesenchymal transition (EMT) is a critical process in invasion and metastasis of cancer cells. E-cadherin to N-cadherin switching is considered a molecular hallmark of EMT. Recently, we reported that increased CK2 activity fully induces E-cadherin to N-cadherin switching, but the molecular mechanisms of N-cadherin upregulation are unknown. In this study, we examined how N-cadherin is upregulated by CK2. N-cadherin promoter analysis and ChIP analysis identified and confirmed myeloid zinc finger 1 (MZF1) as an N-cadherin transcription factor. Molecular analysis showed that MZF1 directly interacts with CK2 and is phosphorylated at serine 27. Phosphorylation stabilizes MZF1 and induces transcription of N-cadherin. MZF1 knockdown (MKD) in N-cadherin-expressing cancer cells downregulates N-cadherin expression and reverts the morphology from spindle and fibroblast-like to a rounded, epithelial shape. In addition, we showed that that MKD reduced the motility and invasiveness of N-cadherin-expressing cancer cells. Collectively, these data indicate that N-cadherin upregulation in CK2-mediated E-cadherin to N-cadherin switching is dependent on phosphorylation-mediated MZF1 stabilization. CK2 could be a good therapeutic target for the prevention of metastasis.

Citing Articles

P4HB regulates the TGFβ/SMAD3 signaling pathway through PRMT1 to participate in high glucose-induced epithelial-mesenchymal transition and fibrosis of renal tubular epithelial cells.

Wang H, Li Y, Wu N, Lv C, Wang Y BMC Nephrol. 2024; 25(1):297.

PMID: 39251943 PMC: 11385120. DOI: 10.1186/s12882-024-03733-5.


YAP1 controls the N-cadherin-mediated tumor-stroma interaction in melanoma progression.

Xio Y, Zhou L, Andl T, Zhang Y Res Sq. 2023; .

PMID: 37546745 PMC: 10402251. DOI: 10.21203/rs.3.rs-2944243/v3.


Stress-Inducible SCAND Factors Suppress the Stress Response and Are Biomarkers for Enhanced Prognosis in Cancers.

Sheta M, Yoshida K, Kanemoto H, Calderwood S, Eguchi T Int J Mol Sci. 2023; 24(6.

PMID: 36982267 PMC: 10049278. DOI: 10.3390/ijms24065168.


SCAND1 Reverses Epithelial-to-Mesenchymal Transition (EMT) and Suppresses Prostate Cancer Growth and Migration.

Eguchi T, Csizmadia E, Kawai H, Sheta M, Yoshida K, Prince T Cells. 2022; 11(24).

PMID: 36552758 PMC: 9777339. DOI: 10.3390/cells11243993.


Proteomics-Based Identification of Dysregulated Proteins in Breast Cancer.

Neagu A, Jayathirtha M, Whitham D, Mutsengi P, Sullivan I, Petre B Proteomes. 2022; 10(4).

PMID: 36278695 PMC: 9590004. DOI: 10.3390/proteomes10040035.


References
1.
Wong Y, Lee T, Liang H, Huang C, Wang T, Yang Y . KinasePhos 2.0: a web server for identifying protein kinase-specific phosphorylation sites based on sequences and coupling patterns. Nucleic Acids Res. 2007; 35(Web Server issue):W588-94. PMC: 1933228. DOI: 10.1093/nar/gkm322. View

2.
Mudduluru G, Vajkoczy P, Allgayer H . Myeloid zinc finger 1 induces migration, invasion, and in vivo metastasis through Axl gene expression in solid cancer. Mol Cancer Res. 2010; 8(2):159-69. DOI: 10.1158/1541-7786.MCR-09-0326. View

3.
Song K, Goke R, Wilmen A, Seidel C, Goke A, Hilliard B . Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is an inhibitor of autoimmune inflammation and cell cycle progression. J Exp Med. 2000; 191(7):1095-104. PMC: 2193179. DOI: 10.1084/jem.191.7.1095. View

4.
Pinna L . Casein kinase 2: an 'eminence grise' in cellular regulation?. Biochim Biophys Acta. 1990; 1054(3):267-84. DOI: 10.1016/0167-4889(90)90098-x. View

5.
Eger A, Aigner K, Sonderegger S, Dampier B, Oehler S, Schreiber M . DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells. Oncogene. 2005; 24(14):2375-85. DOI: 10.1038/sj.onc.1208429. View